glutathione depletion and oxidative stress Participation in the Prevention of Cardiovascular Diseases Current Insights into Glutathione Depletion

Richens TR, Linderman DJ, Horstmann SA, Lambert C, Xiao Y-Q, Keith RL, et al

Disclosures: Jun Li: Nothing to Disclose, Heng Yao: Nothing to Disclose, Hui Yang: Nothing to Disclose, Suwan Sun: Nothing to Disclose, Xi Liang: Nothing to Disclose, Jing Jiang: Nothing to Disclose, Jiaojiao Xin: Nothing to Disclose, Dongyan Shi: Nothing to Disclose, Xin Chen: Nothing to Disclose 2564 DEVELOPING A MACHINE LEARNING UNIVERSAL PREDICTOR FOR LIVER FIBROSIS PROGRESSION Kirstin Peters 1 Nicholas Valle 1 Jamie Yang 2 Michelle Guan 1 Tien Dong 1 , 1 UCLA, 2 University of California, Los Angeles Background: In the United States, liver disease and transplant rates are escalating despite advancements in managing viral hepatitis, largely driven by alcohol-associated liver disease (ALD) and metabolic dysfunction-associated steatotic liver disease (MASLD), which accounted for 75% of transplants in 2022

If the calculation is correct, consider splitting the dose

This article covers what the research supports, how injections compare to IV infusions, what patients typically experience, and how compounded glutathione is prepared for the patients who receive it